An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples